L&G predicts generation of rehab only GIP products


A new breed of rehabilitation only group risk products is likely to be born if the results of the Sickness Absence Review are followed through, Legal & General has said.

The health and protection insurance industry has welcomed the findings but some concerns were raised about how state benefit claimants could be provided early access to treatment programmes. Health insurer Axa PPP was particularly supportive of the decision to offer tax relief to employers providing private medical insurance (PMI) to basic rate tax payers. It said the report included some ‘bold, constructive recommendations' which if introduced, ‘should significantly improve sickness absence management in Britain'. James Freeston, sales and marketing director at Axa PPP's added: "O...

To continue reading this article...

Join Professional Adviser

  • Unlimited access to real-time news, industry insights and market intelligence.
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters.
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection.
  • Members-only access to the editor’s weekly Friday commentary
 Be the first to hear about our events and awards programmes.



Already a Professional Adviser member?


More on Group Protection